Mechanisms of Pannexin Channel Activation and permeation

Pannexin 通道激活和渗透的机制

基本信息

  • 批准号:
    10407616
  • 负责人:
  • 金额:
    $ 39.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT 4 PROJECT SUMMARY Pannexin 1 (Panx1) is a widely-expressed membrane ion channel that, when activated, leads to transmembrane flux of large molecules (i.e., nucleotides, other metabolites) that can mediate intercellular signaling in multiple (patho)physiological contexts (e.g., see Projects 1-3). Thus, understanding the different cellular and molecular mechanisms for channel activation, and the determinants for large molecule permeation, are of paramount importance to reveal novel potential therapeutic strategies for pathway-specific pharmacological intervention that could selectively modulate permeation of specific signaling metabolites in different contexts. Among well-established Panx1 activation mechanisms, that mediated by Gαq protein-coupled receptors (GαqPCRs) is widespread, but the essential cellular, molecular and biophysical mechanisms that mediate this prevalent form of channel activation have not been elucidated. Our preliminary data implicate the salt-inducible kinase, SIK1, a serine-threonine kinase that physically associates with Panx1, and is both necessary and sufficient for channel activation. In Aim 1, supported by additional preliminary observations, we test the hypothesis that GαqPCRs signal via non-canonical pathways involving LKB1 and RhoA-mDia-HDAC6, which converge to activate SIK1 to mediate phosphorylation and activation of Panx1. For this, we use genetic and pharmacological tools, in heterologous and native systems, to determine the relevant signaling pathways and identify critical channel phosphosites by mutational, mass spectrometric and in vitro kinase approaches. In addition, we use single channel recordings to characterize properties of partially and fully receptor-activated wild type and concatenated Panx1 constructs, examining whether channels activate in the novel stepwise fashion that we recently discovered for C-terminally cleavage-activated channels. Panx1 channels are renowned for their association with nucleotide release and dye uptake. Nonetheless, it has not been established whether these large molecules actually permeate via the channel itself, and even the ionic selectivity of Panx1 has not been established. In addition, channels activated by different mechanisms display distinct single channel properties, suggesting that they may also yield distinct permeation properties that support release of specific signaling molecules. In Aim 2, we implement a proteoliposome system incorporating purified Panx1 to test the hypothesis that activated Panx1 provides a permeation pathway that supports release of various cellular constituents, and that flux of different molecules is influenced by distinct modes of channel activation. By directly measuring permeation of specific signaling metabolites through these purified Panx1 channels, we will identify the range of metabolites that can transit the channel when activated by either caspase- mediated C-terminal cleavage or SIK1-mediated phosphorylation. This work defines molecular mechanisms underlying physiologically relevant forms of Panx1 regulation, and identifies permeation properties and signaling metabolites supported by specific activation mechanisms.
项目4项目概要 Pannexin 1(Panx 1)是一种广泛表达的膜离子通道,当被激活时,导致跨膜 大分子的通量(即,核苷酸,其他代谢物),可以介导多种细胞间信号传导, (病态)生理环境(例如,见项目1-3)。因此,了解不同的细胞和分子 通道激活的机制和大分子渗透的决定因素是至关重要的 揭示途径特异性药理学干预新的潜在治疗策略的重要性, 可以选择性地调节特定信号代谢物在不同环境中的渗透。 在公认的Panx 1激活机制中,Gαq蛋白偶联受体介导的 (Gα qPCR)是广泛的,但介导这一点的基本细胞,分子和生物物理机制, 尚未阐明通道激活的普遍形式。我们的初步数据表明, 激酶,SIK 1,一种丝氨酸-苏氨酸激酶,与Panx 1物理结合,是必需的, 足以激活通道。在目标1中,通过额外的初步观察,我们测试了 假设Gα qPCR通过涉及LKB 1和RhoA-mDia-HDAC 6的非经典途径进行信号传导, 汇聚激活SIK 1介导磷酸化和激活Panx 1。为此,我们使用基因和 药理学工具,在异源和天然系统中,以确定相关的信号传导途径, 通过突变、质谱和体外激酶方法鉴定关键通道磷酸化位点。在 此外,我们使用单通道记录来表征部分和完全受体激活的野生型 类型和串联Panx 1结构,检查通道是否以新颖的逐步方式激活 我们最近发现的C端裂解激活通道。 Panx 1通道以其与核苷酸释放和染料摄取的关联而闻名。尽管如此, 还没有确定这些大分子是否真的通过通道本身渗透,甚至 Panx 1的离子选择性尚未确定。此外,由不同机制激活的通道 显示出独特的单通道特性,这表明它们也可以产生独特的渗透特性, 支持特定信号分子的释放。在目标2中,我们实现了一个蛋白脂质体系统, 纯化的Panx 1,以测试活化的Panx 1提供支持释放的渗透途径的假设 不同的细胞成分,以及不同的分子流量是由不同的通道模式的影响, activation.通过直接测量特定信号传导代谢物通过这些纯化的Panx 1的渗透, 通道,我们将确定代谢物的范围,可以通过通道时,激活半胱天冬酶, 介导的C-末端切割或SIK 1介导的磷酸化。 这项工作定义了生理相关形式的Panx 1调节的分子机制, 确定渗透性能和信号代谢物支持的特定激活机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas A. Bayliss其他文献

Permeation Properties of Purified Pannexin 1 Channels in Proteoliposomes
  • DOI:
    10.1016/j.bpj.2019.11.2362
  • 发表时间:
    2020-02-07
  • 期刊:
  • 影响因子:
  • 作者:
    Adishesh K. Narahari;Alex J. Kreutzberger;Susan Leonhardt;Xueyao Jin;Pablo Pauchard;Christopher B. Medina;Volker Kiessling;Kodi Ravichandran;Jorge E. Contreras;Lukas K. Tamm;Mark Yeager;Douglas A. Bayliss
  • 通讯作者:
    Douglas A. Bayliss
Electrophysiology of Concatameric Pannexin 1 Channels Reveals the Stoichiometry of C-Terminal Autoinhibition
  • DOI:
    10.1016/j.bpj.2012.11.3496
  • 发表时间:
    2013-01-29
  • 期刊:
  • 影响因子:
  • 作者:
    Yu-Hsin Chiu;Joanna K. Sandilos;Volker Kiessling;Susan A. Leonhardt;Mark Yeager;Lukas K. Tamm;Kodi S. Ravichandran;Douglas A. Bayliss
  • 通讯作者:
    Douglas A. Bayliss
Caspases Mediate Pannexin 1 Channel Activation in Apoptotic Cells
  • DOI:
    10.1016/j.bpj.2010.12.759
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Joanna K. Sandilos;Faraaz B. Chekeni;Michael R. Elliott;Scott F. Walk;Jason M. Kinchen;Eduardo R. Lazarowski;Allison J. Armstrong;Silvia Penuela;Dale W. Laird;Guy S. Salvesen;Brant E. Isakson;Kodi S. Ravichandran;Douglas A. Bayliss
  • 通讯作者:
    Douglas A. Bayliss

Douglas A. Bayliss的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas A. Bayliss', 18)}}的其他基金

Pannexin Channels In Vascular Physiology & Inflammation
血管生理学中的 Pannexin 通道
  • 批准号:
    10200118
  • 财政年份:
    2014
  • 资助金额:
    $ 39.79万
  • 项目类别:
Mechanisms of Pannexin Channel Activation and permeation
Pannexin 通道激活和渗透的机制
  • 批准号:
    10625334
  • 财政年份:
    2014
  • 资助金额:
    $ 39.79万
  • 项目类别:
Pannexin Channels In Vascular Physiology & Inflammation
血管生理学中的 Pannexin 通道
  • 批准号:
    10407608
  • 财政年份:
    2014
  • 资助金额:
    $ 39.79万
  • 项目类别:
Mechanisms of Pannexin Channel Activation and permeation
Pannexin 通道激活和渗透的机制
  • 批准号:
    10200125
  • 财政年份:
    2014
  • 资助金额:
    $ 39.79万
  • 项目类别:
Pannexin Channels In Vascular Physiology & Inflammation
血管生理学中的 Pannexin 通道
  • 批准号:
    10625317
  • 财政年份:
    2014
  • 资助金额:
    $ 39.79万
  • 项目类别:
Release of find-me signals during apoptotic cell clearance
在凋亡细胞清除过程中释放“找到我”信号
  • 批准号:
    8730208
  • 财政年份:
    2013
  • 资助金额:
    $ 39.79万
  • 项目类别:
Release of find-me signals during apoptotic cell clearance
在凋亡细胞清除过程中释放“找到我”信号
  • 批准号:
    8562561
  • 财政年份:
    2013
  • 资助金额:
    $ 39.79万
  • 项目类别:
Release of find-me signals during apoptotic cell clearance
在凋亡细胞清除过程中释放“找到我”信号
  • 批准号:
    9066751
  • 财政年份:
    2013
  • 资助金额:
    $ 39.79万
  • 项目类别:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
呼吸神经元化学敏感性的细胞/分子机制
  • 批准号:
    10321300
  • 财政年份:
    2011
  • 资助金额:
    $ 39.79万
  • 项目类别:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
呼吸神经元化学敏感性的细胞/分子机制
  • 批准号:
    8461983
  • 财政年份:
    2011
  • 资助金额:
    $ 39.79万
  • 项目类别:

相似海外基金

Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
  • 批准号:
    10603466
  • 财政年份:
    2023
  • 资助金额:
    $ 39.79万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
    Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
  • 批准号:
    RGPIN-2019-04706
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
    University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10629280
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10448574
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
  • 批准号:
    10591688
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
    University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
  • 批准号:
    22K07118
  • 财政年份:
    2022
  • 资助金额:
    $ 39.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了